Latest Patents News

Zoono Group Limited is raising nearly $1.8 million through a non-renounceable rights issue to fund its supermarket shelf-life extension project in Asia and reduce related party debt.

Everest Metals has been accepted into the US Defence Industrial Base Consortium, unlocking strategic collaboration and funding opportunities for its Mt Edon Rubidium Project in Western Australia. This milestone advances Australia’s first commercial rubidium production, addressing critical global supply shortages.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.

4DMedical has renewed and expanded its contract with Stanford University’s 3DQ Lab to include its innovative CT – VQ™ imaging technology ahead of FDA clearance, marking a significant step in its U.S. market expansion.

Volt Resources has completed a scoping study for its Alabama Graphite Refinery, revealing robust project economics and a patented purification process that could reshape US graphite supply chains.

Impact Minerals Limited has released a robust Preliminary Feasibility Study for its Lake Hope High Purity Alumina project, revealing strong economics and a maiden Ore Reserve. The company is advancing towards a Definitive Feasibility Study and pilot plant construction, positioning itself for low-cost, low-carbon HPA production.

Hazer Group unveils a strategic alliance with engineering giant KBR to fast-track its low-cost clean hydrogen technology, targeting major global markets with a capex-lite licensing model.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

dorsaVi has secured exclusive worldwide rights to cutting-edge RRAM technology from NTU Singapore, promising to revolutionize its wearable sensor products with enhanced performance and energy efficiency. This strategic move positions the company for expansion into healthcare, elite sports, and industrial IoT markets.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.